PTBD Stenting in Cholangiocarcinoma Patients with Coagulopathy

Critical Pre-Procedure Assessment

The American College of Radiology recommends that PTBD is absolutely contraindicated in patients with uncorrected coagulopathy, as bleeding complications occur in approximately 2.5% of cases overall, with significantly higher risk when coagulation is abnormal 1, 2
Coagulation status, including PT/INR, PTT, and platelet count, should be checked immediately, as hyperbilirubinemia commonly causes coagulopathy through cholestasis and vitamin K deficiency 3, 1
If INR is elevated, vitamin K supplementation should be administered before attributing prolonged INR solely to liver dysfunction, as fat-soluble vitamin deficiencies are correctable 4
Coagulopathy should be corrected to INR <1.5 and platelets >50,000/μL before proceeding with PTBD 1

The American College of Radiology states that a hemoglobin level of 7.79 g/dL does not preclude the procedure but requires optimization, and consider transfusing to hemoglobin ≥8 g/dL before the procedure to provide a safety margin 1, 2

The American College of Radiology recommends that endoscopic biliary drainage (ERCP with stenting) is the procedure of choice in patients with coagulopathy, as it carries significantly lower bleeding risk than PTBD 1, 2
The bleeding risk with therapeutic ERCP is primarily associated with biliary sphincterotomy (1-2% rate), and alternative approaches like balloon sphincteroplasty can be performed when reversal is contraindicated 1, 2

The International Journal of Surgery states that routine preoperative biliary drainage (PBD) is not recommended for all cholangiocarcinoma patients, as it increases risks of morbidity, infection, transfusion requirements, bile leakage, and cholangitis 3, 5, 6, 7
PBD becomes beneficial primarily when initial bilirubin is >218.75 μmol/L (approximately 12.8 mg/dL), where it reduces postoperative hepatic insufficiency 3, 5, 7

Bilateral drainage is often necessary rather than unilateral PTBD in hilar obstruction—at least 50% of functional liver parenchyma must be drained for effective bilirubin reduction 8
Single catheter placement frequently provides inadequate drainage in hilar tumors 8
Prophylactic antibiotics should be administered during placement, as PTBD introduces significant infection risk 8

The American College of Radiology advises not to proceed with PTBD if coagulopathy is uncorrected, as this is the primary contraindication, not the hemoglobin level 1, 2
The American College of Radiology recommends not to assume endoscopic drainage is impossible, and ERCP should be attempted first in coagulopathic patients before considering PTBD 1, 2
The International Journal of Surgery and Praxis Medical Insights advise not to forget vitamin K supplementation, as cholestatic patients commonly have correctable coagulopathy from vitamin K deficiency 3, 4